Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome

Background--Intestinal microbiota have been found to be linked to cardiovascular disease via conversion of the dietary compounds choline and carnitine to the atherogenic metabolite TMAO (trimethylamine-N-oxide). Specifically, a vegan diet was associated with decreased plasma TMAO levels and nearly absent TMAO production on carnitine challenge. Methods and Results--We performed a double-blind randomized controlled pilot study in which 20 male metabolic syndrome patients were randomized to single lean vegan-donor or autologous fecal microbiota transplantation. At baseline and 2 weeks thereafter, we determined the ability to produce TMAO from d6-choline and d3-carnitine (eg, labeled and unlabeled TMAO in plasma and 24-hour urine after oral ingestion of 250 mg of both isotope-labeled precursor nutrients), and fecal samples were collected for analysis of microbiota composition. 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans of the abdominal aorta, as well as ex vivo peripheral blood mononuclear cell cytokine production assays, were performed. At baseline, fecal microbiota composition differed significantly between vegans and metabolic syndrome patients. With vegan-donor fecal microbiota transplantation, intestinal microbiota composition in metabolic syndrome patients, as monitored by global fecal microbial community structure, changed toward a vegan profile in some of the patients; however, no functional effects from vegan-donor fecal microbiota transplantation were seen on TMAO production, abdominal aortic 18Ffluorodeoxyglucose uptake, or ex vivo cytokine production from peripheral blood mononuclear cells. Conclusions--Single lean vegan-donor fecal microbiota transplantation in metabolic syndrome patients resulted in detectable changes in intestinal microbiota composition but failed to elicit changes in TMAO production capacity or parameters related to vascular inflammation.

Saved in:
Bibliographic Details
Main Authors: Smits, Loek P., Kootte, Ruud S., Levin, Evgeni, Prodan, Andrei, Fuentes, Susana, Zoetendal, Erwin G., Wang, Zeneng, Levison, Bruce S., Cleophas, Maartje C.P., Kemper, E.M., Dallinga-Thie, Geesje M., Groen, Albert K., Joosten, Leo A.B., Netea, Mihai G., Stroes, Erik S.G., de Vos, Willem M., Hazen, Stanley L., Nieuwdorp, Max
Format: Article/Letter to editor biblioteca
Language:English
Subjects:Atherosclerosis, Cardiovascular disease, Cardiovascular imaging, Inflammation, Metabolism,
Online Access:https://research.wur.nl/en/publications/effect-of-vegan-fecal-microbiota-transplantation-on-carnitine-and
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-wur-nl-wurpubs-536429
record_format koha
spelling dig-wur-nl-wurpubs-5364292024-10-30 Smits, Loek P. Kootte, Ruud S. Levin, Evgeni Prodan, Andrei Fuentes, Susana Zoetendal, Erwin G. Wang, Zeneng Levison, Bruce S. Cleophas, Maartje C.P. Kemper, E.M. Dallinga-Thie, Geesje M. Groen, Albert K. Joosten, Leo A.B. Netea, Mihai G. Stroes, Erik S.G. de Vos, Willem M. Hazen, Stanley L. Nieuwdorp, Max Article/Letter to editor Journal of the American Heart Association 7 (2018) 7 ISSN: 2047-9980 Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome 2018 Background--Intestinal microbiota have been found to be linked to cardiovascular disease via conversion of the dietary compounds choline and carnitine to the atherogenic metabolite TMAO (trimethylamine-N-oxide). Specifically, a vegan diet was associated with decreased plasma TMAO levels and nearly absent TMAO production on carnitine challenge. Methods and Results--We performed a double-blind randomized controlled pilot study in which 20 male metabolic syndrome patients were randomized to single lean vegan-donor or autologous fecal microbiota transplantation. At baseline and 2 weeks thereafter, we determined the ability to produce TMAO from d6-choline and d3-carnitine (eg, labeled and unlabeled TMAO in plasma and 24-hour urine after oral ingestion of 250 mg of both isotope-labeled precursor nutrients), and fecal samples were collected for analysis of microbiota composition. 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans of the abdominal aorta, as well as ex vivo peripheral blood mononuclear cell cytokine production assays, were performed. At baseline, fecal microbiota composition differed significantly between vegans and metabolic syndrome patients. With vegan-donor fecal microbiota transplantation, intestinal microbiota composition in metabolic syndrome patients, as monitored by global fecal microbial community structure, changed toward a vegan profile in some of the patients; however, no functional effects from vegan-donor fecal microbiota transplantation were seen on TMAO production, abdominal aortic 18Ffluorodeoxyglucose uptake, or ex vivo cytokine production from peripheral blood mononuclear cells. Conclusions--Single lean vegan-donor fecal microbiota transplantation in metabolic syndrome patients resulted in detectable changes in intestinal microbiota composition but failed to elicit changes in TMAO production capacity or parameters related to vascular inflammation. en application/pdf https://research.wur.nl/en/publications/effect-of-vegan-fecal-microbiota-transplantation-on-carnitine-and 10.1161/JAHA.117.008342 https://edepot.wur.nl/446870 Atherosclerosis Cardiovascular disease Cardiovascular imaging Inflammation Metabolism https://creativecommons.org/licenses/by-nc-nd/4.0/ Wageningen University & Research
institution WUR NL
collection DSpace
country Países bajos
countrycode NL
component Bibliográfico
access En linea
databasecode dig-wur-nl
tag biblioteca
region Europa del Oeste
libraryname WUR Library Netherlands
language English
topic Atherosclerosis
Cardiovascular disease
Cardiovascular imaging
Inflammation
Metabolism
Atherosclerosis
Cardiovascular disease
Cardiovascular imaging
Inflammation
Metabolism
spellingShingle Atherosclerosis
Cardiovascular disease
Cardiovascular imaging
Inflammation
Metabolism
Atherosclerosis
Cardiovascular disease
Cardiovascular imaging
Inflammation
Metabolism
Smits, Loek P.
Kootte, Ruud S.
Levin, Evgeni
Prodan, Andrei
Fuentes, Susana
Zoetendal, Erwin G.
Wang, Zeneng
Levison, Bruce S.
Cleophas, Maartje C.P.
Kemper, E.M.
Dallinga-Thie, Geesje M.
Groen, Albert K.
Joosten, Leo A.B.
Netea, Mihai G.
Stroes, Erik S.G.
de Vos, Willem M.
Hazen, Stanley L.
Nieuwdorp, Max
Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome
description Background--Intestinal microbiota have been found to be linked to cardiovascular disease via conversion of the dietary compounds choline and carnitine to the atherogenic metabolite TMAO (trimethylamine-N-oxide). Specifically, a vegan diet was associated with decreased plasma TMAO levels and nearly absent TMAO production on carnitine challenge. Methods and Results--We performed a double-blind randomized controlled pilot study in which 20 male metabolic syndrome patients were randomized to single lean vegan-donor or autologous fecal microbiota transplantation. At baseline and 2 weeks thereafter, we determined the ability to produce TMAO from d6-choline and d3-carnitine (eg, labeled and unlabeled TMAO in plasma and 24-hour urine after oral ingestion of 250 mg of both isotope-labeled precursor nutrients), and fecal samples were collected for analysis of microbiota composition. 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans of the abdominal aorta, as well as ex vivo peripheral blood mononuclear cell cytokine production assays, were performed. At baseline, fecal microbiota composition differed significantly between vegans and metabolic syndrome patients. With vegan-donor fecal microbiota transplantation, intestinal microbiota composition in metabolic syndrome patients, as monitored by global fecal microbial community structure, changed toward a vegan profile in some of the patients; however, no functional effects from vegan-donor fecal microbiota transplantation were seen on TMAO production, abdominal aortic 18Ffluorodeoxyglucose uptake, or ex vivo cytokine production from peripheral blood mononuclear cells. Conclusions--Single lean vegan-donor fecal microbiota transplantation in metabolic syndrome patients resulted in detectable changes in intestinal microbiota composition but failed to elicit changes in TMAO production capacity or parameters related to vascular inflammation.
format Article/Letter to editor
topic_facet Atherosclerosis
Cardiovascular disease
Cardiovascular imaging
Inflammation
Metabolism
author Smits, Loek P.
Kootte, Ruud S.
Levin, Evgeni
Prodan, Andrei
Fuentes, Susana
Zoetendal, Erwin G.
Wang, Zeneng
Levison, Bruce S.
Cleophas, Maartje C.P.
Kemper, E.M.
Dallinga-Thie, Geesje M.
Groen, Albert K.
Joosten, Leo A.B.
Netea, Mihai G.
Stroes, Erik S.G.
de Vos, Willem M.
Hazen, Stanley L.
Nieuwdorp, Max
author_facet Smits, Loek P.
Kootte, Ruud S.
Levin, Evgeni
Prodan, Andrei
Fuentes, Susana
Zoetendal, Erwin G.
Wang, Zeneng
Levison, Bruce S.
Cleophas, Maartje C.P.
Kemper, E.M.
Dallinga-Thie, Geesje M.
Groen, Albert K.
Joosten, Leo A.B.
Netea, Mihai G.
Stroes, Erik S.G.
de Vos, Willem M.
Hazen, Stanley L.
Nieuwdorp, Max
author_sort Smits, Loek P.
title Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome
title_short Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome
title_full Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome
title_fullStr Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome
title_full_unstemmed Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome
title_sort effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-n-oxide production and vascular inflammation in patients with metabolic syndrome
url https://research.wur.nl/en/publications/effect-of-vegan-fecal-microbiota-transplantation-on-carnitine-and
work_keys_str_mv AT smitsloekp effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT kootteruuds effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT levinevgeni effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT prodanandrei effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT fuentessusana effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT zoetendalerwing effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT wangzeneng effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT levisonbruces effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT cleophasmaartjecp effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT kemperem effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT dallingathiegeesjem effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT groenalbertk effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT joostenleoab effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT neteamihaig effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT stroeseriksg effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT devoswillemm effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT hazenstanleyl effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
AT nieuwdorpmax effectofveganfecalmicrobiotatransplantationoncarnitineandcholinederivedtrimethylaminenoxideproductionandvascularinflammationinpatientswithmetabolicsyndrome
_version_ 1816157199432417280